Resurgence of Ebola virus disease in guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days
Research output: Contribution to journal › Article
Colleges, School and Institutes
- World Health Organization, Conakry, Guinea.
- INSERM U1219, Bordeaux University, and.
- Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom.
- Laboratoire des Fièvres Hémorragiques en Guinée, Hôpital Donka et N'Zérékoré.
- Centers for Disease Control and Prevention (CDC) Guinea Response Team, Conakry.
- European Mobile Laboratory Consortium, Hamburg, Germany.
- University of Cambridge
- European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom, CB10 1SD.
- Department of Public Health, University of Makeni, Sierra Leone.
- Université Gamal Abdel Nasser de Conakry, Laboratoire des Fièvres Hémorragiques en Guinée, Conakry, Guinea.
- World Health Organization, Geneva, Switzerland; and.
- Ministry of Health, Conakry, Guinea.
- Institute for Evolutionary Biology, Centre for Infection, Immunity and Evolution, Ashworth Laboratories, University of Edinburgh, United Kingdom.
We report on an Ebola virus disease (EVD) survivor who showed Ebola virus in seminal fluid 531 days after onset of disease. The persisting virus was sexually transmitted in February 2016, about 470 days after onset of symptoms, and caused a new cluster of EVD in Guinea and Liberia.
|Number of pages||4|
|Journal||Clinical Infectious Diseases|
|Early online date||Sep 2016|
|Publication status||Published - 15 Nov 2016|